The INFI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the INFI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The INFI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View INFI Detailed Price Forecast - CNN Money||View INFI Detailed Summary - Google Finance|
|View INFI Detailed Summary - Yahoo! Finance||View INFI Stock Research & Analysis - Zacks.com|
|View INFI Trends & Analysis - Trade-Ideas||View INFI Major Holders - Barrons|
|View INFI Call Transcripts - NASDAQ||View INFI Breaking News & Analysis - Seeking Alpha|
|View INFI Annual Report - CompanySpotlight.com||View INFI OTC Short Report - OTCShortReport.com|
|View INFI Fundamentals - TradeKing||View INFI SEC Filings - Bar Chart|
|View Historical Prices for INFI - The WSJ||View Performance/Total Return for INFI - Morningstar|
|View the Analyst Estimates for INFI - MarketWatch||View the Earnings History for INFI - CNBC|
|View the INFI Earnings - StockMarketWatch||View INFI Buy or Sell Recommendations - MacroAxis|
|View the INFI Bullish Patterns - American Bulls||View INFI Short Pain Metrics - ShortPainBot.com|
|View INFI Stock Mentions - StockTwits||View INFI Stock Mentions - PennyStockTweets|
|View INFI Stock Mentions - Twitter||View INFI Investment Forum News - Investor Hub|
|View INFI Stock Mentions - Yahoo! Message Board||View INFI Stock Mentions - Seeking Alpha|
|View Insider Transactions for INFI - SECform4.com||View Insider Transactions for INFI - Insider Cow|
|View INFI Major Holdings Summary - CNBC||View Insider Disclosure for INFI - OTC Markets|
|View Insider Transactions for INFI - Yahoo! Finance||View Institutional Holdings for INFI - NASDAQ|
|View INFI Stock Insight & Charts - FinViz.com||View INFI Investment Charts - StockCharts.com|
|View INFI Stock Overview & Charts - BarChart||View INFI User Generated Charts - Trading View|
Free Technical Research on Insmed and Three More Biotech Equities
Posted on Friday July 13, 2018
On Thursday, July 12, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged higher at the closing bell. All sectors ended Wednesday's trading session in bullish territories. Taking into consideration yesterday's market sentiment, WallStEquities.com assessed the following Biotechnology equities this morning: Infinity Pharmaceuticals Inc. (NASDAQ: INFI), Innoviva Inc. (NASDAQ: INVA), Inovio Pharmaceuticals Inc. (NASDAQ: INO), and Insmed Inc. (NASDAQ: INSM).
Infinity and Arcus Ink Deal for Two Triple Combo Studies
Posted on Wednesday June 27, 2018
: Infinity Pharmaceuticals, Inc. (INFI) and Arcus Biosciences, Inc. (RCUS) sign a deal to evaluate two triple combination therapies in selected tumor types.
HAYWARD, Calif. and CAMBRIDGE, Mass., June 26, 2018 /PRNewswire/ -- Arcus Biosciences, Inc. (RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies, and Infinity Pharmaceuticals, Inc. (INFI), a clinical-stage biopharmaceutical company developing IPI-549, a first-in-class immuno-oncology product candidate that selectively inhibits phosphoinositide-3-kinase gamma (PI3K-gamma), today announced that they have entered into a clinical collaboration to evaluate two triple combination therapies in selected tumor types which typically show minimal response to checkpoint inhibition monotherapy. The collaboration will evaluate IPI-549 in combination with AB928, Arcus's dual adenosine receptor antagonist, and AB122, Arcus's anti-PD-1 antibody, as well as IPI-549 in combination with AB928 and chemotherapy in patients with triple negative breast cancer (TNBC) or ovarian cancer in four separate cohorts.
Is the Options Market Predicting a Spike in Infinity (INFI) Stock?
Posted on Monday June 25, 2018
Investors in Infinity (INFI) need to pay close attention to the stock based on moves in the options market lately.